Brexit deal: What it really means for cancer research and innovation

NCRI
2/11/21, 10:00 AM
Europe/London GMT+1

Description

Having left the EU during a global pandemic with a deal, the research and innovation landscape in the UK is set to change. This session will review the current situation and discuss how things are looking from the perspective of some key organisations and experts in the UK. Speakers will address challenges and opportunities and suggest what needs to happen to allow the UK to remain at the forefront of cancer research. Participants will get a better understanding of the current situation with regards to EU funding, grants and alternative research funding schemes. They will hear about current challenges and opportunities and learn what can be done to address them. Following the session, participants will have a clearer understanding of the changes and the choices to make to continue to attract funding and be successful in international collaborations.

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

Pamela Kearns

Brexit deal: What it really means for cancer research and innovation

Inglês

 

Speakers

Sheuli Porkess, Richard Sullivan, Emlyn Samuel, Jim Elliott